Opko Health, Inc. (NYSE:OPK)

little upside

I think that OPK has alot of potential to the upside. It is trying to establish a foothold in a great industry and has made some aquisitions that will help in the near ftrure. I would buy this and hold to see if other investors have the same thoughts.

jim cramer long term one year should hit a billion in revenues

Bozzazz

OPKO health is a pure play on Dr. Philip Frost and his ability to create companies in this sector and then sell them for large shareholder gains. Dr. Frost also continues to be a buyer in the M+A world of little known company's that fit into what he is trying to accomplish.

My gut tells me to never bet against self made men like Dr. Philip Frost and I'm going to ride his coat tails this time. He obviously believes in what he is doing as he has continually purchases shares in this company, over the counter, for the last 2 years.

I see a lot of speculation here about a buyout, but let's get back to reality. It doesn't seem likely that any company will pay over $2 billion for just $170 million in net assets and less than $40 million in annual revenue. Opko goes from a measly $5-$6 million in quarterly revenue to $11 and all of a sudden its the best company ever? Look closer and you'll see that a near doubling in revenue resulted in an even larger loss than last year!

pipeline of novel in house testing for doctors

CEO is genius billionaire making a the right moves

It will snapped up by one of the big pharmas

Insiders buying on insider insight on insider information. Three good reasons to buy now.

CEO is buying a ton of shares, so I'm initiating this to see what happens.

Nice technicals, and management!

All Health stocks are going to do well as baby boomers all retire and government fans the flames of health care.

barely any revenue & no product forthcoming (2-3 years) does not equal a $1.4bn market cap.

i think they are creating turbulence by insider trading

Stock is undervalued relative to the comps. Market is just a little slow to realize it. Comps in Biotech averaging $5B market cap.

Heaving insider purchase.

This little biotech play has been steadly moving in the right direction for some time. Don't miss out. They have a solid BOD.

Covestor Model Manager William Smith sold OPK in his Price Volatility Volume Covestor Model ( http://covestor.com/William-Smith )